Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients [0.03%]
低体重患者静脉血栓栓塞预防用依诺肝素剂量研究
Daniel Dybdahl,Grant Walliser,Michelle Pershing et al.
Daniel Dybdahl et al.
Background: The appropriate dose of enoxaparin for venous thromboembolism (VTE) prophylaxis in low body weight patients is unknown. Objective: ...
Effects of Serum Albumin Levels on Antithrombin Supplementation Outcomes Among Patients With Sepsis-Associated Coagulopathy: A Retrospective Study [0.03%]
血清白蛋白水平对脓毒症相关凝血病患者抗凝血酶补充疗效的影响：一项回顾性研究
Masatomo Ebina,Kazunori Fujino,Akira Inoue et al.
Masatomo Ebina et al.
Background: Severe sepsis is commonly associated with mortality among critically ill patients and is known to cause coagulopathy. While antithrombin is an anticoagulant used in this setting, serum albumin levels are known...
Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia [0.03%]
以急性白血病形式表现的弥漫性大B细胞淋巴瘤白血病期复发病例
Priyavadhana Balasubramanian,Prashant Ramteke,Saumyaranjan Mallick et al.
Priyavadhana Balasubramanian et al.
Diffuse large B-cell lymphoma (DLBCL) accounts for 30% to 40% of the newly diagnosed adult non-Hodgkin lymphomas, but rarely presents in leukaemic phase. Here in, we report a case of DLBCL presenting in leukaemic phase and masquerading as a...
Routine Preoperative Coagulation Tests in Children Undergoing Elective Surgery or Invasive Procedures: Are They Still Necessary? [0.03%]
择期手术或侵入性操作的儿童常规术前凝血检查有必要吗？
Azzah Alzahrani,Nada Othman,Tahani Bin-Ali et al.
Azzah Alzahrani et al.
Introduction: Preoperative coagulation screening tests in pediatric patients was once routine clinical practice globally and still used as standard practice in some countries before surgical procedures to assess of periop...
Efficacy of Afternoon Plerixafor Administration for Stem Cell Mobilization [0.03%]
下午使用普乐沙福进行干细胞动员的效果
Cynthia El Rahi,James Eldin Cox,Romelia May et al.
Cynthia El Rahi et al.
Background: When used for hematopoietic stem cell mobilization, plerixafor was originally recommended to be administered 11 hours prior to apheresis based on the peak effect of 10 to 14 hours translating into an administr...
The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [0.03%]
《潜水钟与蝴蝶》重现：以 Epstein-Barr病毒阳性的非特指型弥漫性大B细胞淋巴瘤导致闭锁综合征死亡的一例报告
Jacqueline N Poston,Russell Dorer,David M Aboulafia
Jacqueline N Poston
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a rare variant of DLBCL. The natural history of this subtype is poorly understood. Incomplete literature in the era of rituximab suggests that patients with EBV-posi...
Denise C Cornelius
Denise C Cornelius
Preeclampsia (PE) affects 5% to 7% of pregnant women each year worldwide, accounts for up to 18% of maternal deaths in the United States each year, and is the number 1 cause of premature births. Preeclampsia is associated with hypertension ...
Effect of the Ginger Derivative, 6-Shogaol, on Ferritin Levels in Patients With Low to Intermediate-1-Risk Myelodysplastic Syndrome-A Small, Investigative Study [0.03%]
姜黄素衍生物6-шogaol对低危和中低危骨髓增生异常综合征患者铁蛋白水平影响的研究
Terry Golombick,Terrence H Diamond,Arumugam Manoharan et al.
Terry Golombick et al.
Background: Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders characterized by dysplastic and ineffective hematopoiesis and peripheral cytopenias. Elevated serum ferritin (SF) is often ...
Afaf H Al Battah,Einas A Al Kuwari,Zsolt Hascsi et al.
Afaf H Al Battah et al.
Primary breast lymphoma (PBL) is a rare disease, and few clinicohistopathologic features of the disease have been discussed in previous studies. It represents 2.2% of extranodal lymphomas and constitutes 0.04% to 0.5% of malignant breast ne...
Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma [0.03%]
面向外周T细胞淋巴瘤治疗策略的生物学方法
Cat Hildyard,S Shiekh,Jab Browning et al.
Cat Hildyard et al.
T-cell and natural killer-cell lymphomas are a relatively rare and heterogeneous group of diseases that are difficult to treat and usually have poor outcomes. To date, therapeutic interventions are of limited efficacy and there is a pressin...